A realization of bench to bedside: Over 2 years from a concept to a test @MSKaccess cell-free DNA liquid biopsy test received NYSDOH approval today - look forward to transforming the way we care for our patients. Excellent team work @MFBerger1@ahmetz@RymaBenayed@MLadanyi
Our #liquidbiopsy test at @sloan_kettering has received NY State DOH approval for clinical use! MSK-ACCESS captures 129 genes, selected from MSK-IMPACT, for high-sensitivity, non-invasive cancer genomic profiling and disease monitoring in plasma cell-free DNA. #ASCO19
π¨ Breaking News - Our #liquidbiopsy test #MSKAccess has received NY State DOH approval for clinical use! MSK-ACCESS captures 129 genes, selected from MSK-IMPACT, for high-sensitivity, non-invasive cancer genomic profiling and disease monitoring in plasma cell-free DNA. #ASCO19